Twist Bioscience Corporation (TWST) Misses Q2 EPS by 5c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.66), $0.05 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $92.79 million versus the consensus estimate of $92.04 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Esquire Financial gets stockholder approval to acquire Signature Bank
• Crown Crafts (CRWS) Reports Q4 EPS of $0.03